The reform has handed over a dazzling "transcript", and each province will collect more than 350 kinds of drugs by the end of the year
The average price of centralized drug purchases has dropped by 50%. What kind of "sense of gain" will this year be?
After the centralized procurement of cardiac stents, the average price dropped from 13,000 yuan to 700 yuan; the domestic version of "Gleevec" in "I am not a drug god" - imatinib mesylate tablets, after centralized procurement even cheaper...
In recent years, the reform of centralized procurement of drugs and high-value medical consumables has been continuously advanced.
Up to now, six batches of national centralized drug procurement have been carried out, a total of 234 drugs have been purchased, and the average price has been reduced by 53%. The purchase amount accounts for 30% of the total annual drug purchases of public medical institutions.
Will falling prices affect the quality of medicines?
What other high-priced drugs and consumables can be "finalist" for centralized procurement?
What kind of "sense of gain" will the common people have with their medicines this year... Focusing on many hot issues that the public cares about and expects, the State Council's policy briefing was held on February 11 on the progress of the reform of the centralized procurement of medicines and high-value medical consumables. At the meeting, the heads of the National Medical Insurance Administration and relevant departments responded.
Price reduction without quality reduction
Wang Chen, who has been taking antihypertensive, lipid-lowering and hypoglycemic drugs for a long time, calculated an account for the reporter: before the centralized drug collection, the lipid-lowering drugs he took were 6 yuan per tablet, and the centralized drugs he was taking were 0.2 yuan per tablet , 4 kinds of medicines together cost about 500 yuan per month before, but now it only costs 110 yuan.
The price of medicine has been reduced, but he also revealed his doubts to the reporter: Can the effect be the same with such a big price difference?
This is also a question shared by many people.
The quality and safety of selected drugs and high-value medical consumables in centralized procurement has always been the focus of public attention and a hot topic of discussion.
"Since the successful bidder won the bid, the price of medicine has dropped by about 50%, which is actually a replacement for the original high sales cost." Chen Jinfu, deputy director of the National Medical Security Administration, said that the procurement and procurement with volume Unity, the company has changed from privately running hospitals and pharmacies to face-to-face quality competition and price competition.
According to the reporter's understanding, the quality of medicines and consumables is not only not falling, but has a tendency to improve while the price is falling.
Taking cardiac stents as an example, data from the National Medical Insurance Bureau shows that 1/3 of stents were originally made of stainless steel, but now the usage rate of chromium alloys in the selected products reaches 95%.
"We always take the quality supervision of the selected products as the top priority." Li Maozhong, head of the Drug Administration Department of the State Drug Administration, introduced, for example, to promote the establishment of an information system for drug variety files, and to cooperate with provincial drug supervision and management departments. Share basic information such as drug production process and quality standards to improve the pertinence of supervision and inspection.
At the same time, traceability management is carried out on the selected drugs in the centralized procurement, and the whole process of drug listing is gradually realized.
"Up to now, according to the results of product sampling and adverse reaction monitoring, no abnormal quality has been found in the varieties selected by the national centralized procurement." Li Maozhong said.
When will the Jamaican Suite end?
Is the era of "planting a tooth and buying a suite in the county" coming to an end?
Last year, the centralized procurement of high-value medical consumables focused on cardiology and orthopaedics, two areas that are most concerned by the masses.
The data at the briefing showed that the average reduction in cardiac stents was 93%, and the average reduction in artificial hip and knee joints was 82%.
The centralized procurement of cardiac stents has been running smoothly for one year, with a total of 1.69 million sets of selected stents, reaching 1.6 times the annual agreement procurement volume.
This year, the centralized procurement of high-value medical consumables will focus on orthopedic consumables, drug balloons, dental implants and other varieties.
"Strive to make more than 5 varieties of high-value medical consumables become the new norm of centralized procurement." Chen Jinfu said.
Drug balloons are important consumables in cardiology.
The reporter noticed that within a period of time after the cardiac stent entered the centralized collection, the use of drug balloons increased significantly.
"Because it is not included in the centralized procurement, there is an artificially high component. Last year, the centralized procurement of drug balloons was carried out in Jiangsu and other places. This year, it will be expanded to the whole country to block the space of artificially high prices." Chen Jinfu said.
Dental implants are an important way to repair missing teeth. The advantages of good chewing effect and long service life make dental implants favored by patients.
But its high price is often intimidating.
Last year, Sichuan organized an inter-provincial alliance to collect information on some high-value oral medical consumables.
This allows many patients to see the hope of reducing the price of dental implants.
"Strive to launch the reform of local alliances for centralized dental implant procurement in the first half of this year, which is a new method of centralized procurement. In the future, the rules of centralized procurement will continue to innovate, which not only meets product quality requirements, but also meets clinical needs. It is necessary to effectively allow enterprises and patients to share the reform results." Chen Jinfu said.
There will be more good drugs "finalists" in the future
In recent years, the reform of centralized procurement of drugs and high-value medical consumables has been continuously advanced.
Judging from the cumulative results of the three-year reform, the state organized centralized procurement to save more than 260 billion yuan.
"Judging from the results achieved, the rules of centralized procurement have been continuously optimized, the quality supervision has become more rigorous, the supply guarantee has become more stable, and the use policy has become more complete. The overall situation has shown a trend of 'price reduction, volume increase, and high quality'." Chen Jinfu According to the introduction, national organizations and alliance procurement have formed a normalized pattern, and centralized procurement bidding regulation, quality, supply, distribution, and use of guarantee mechanisms and supporting policies have also been increasingly improved and optimized.
In the future, how to speed up the expansion of medicines and high-value medical consumables, so that people can enjoy more low-cost good medicines?
"The three major fields are fully covered, and there is no living space to sell with gold." Chen Jinfu said that special procurement of insulin has been launched in 2021, and the centralized procurement will be expanded from chemical drugs to biological drugs for the first time. The three major fields of patent medicine and biological medicine are carried out in an all-round way.
It is understood that at present, the National Medical Insurance Bureau is planning the seventh batch of centralized drug procurement, and strives to achieve an average coverage of more than 350 drug varieties and high-value medical consumables in each province through national organizations and provincial alliance procurement by the end of 2022. There are more than 5 varieties.
Reporter: Zhang Jing